Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Examined by the step-section technique.

PubWeight™: 1.38‹?› | Rank: Top 10%

🔗 View Article (PMID 5064808)

Published in Cancer on July 01, 1972

Authors

D P Byar, F K Mostofi

Articles citing this

Residual tumor potentially left behind after local ablation therapy in prostate adenocarcinoma. J Urol (2008) 1.63

Expression of E-cadherin in primary and metastatic prostate cancer. Am J Pathol (1996) 1.31

Contrast-enhanced ultrasound imaging of prostate cancer. Rev Urol (2006) 1.13

Differential gene expression in benign prostate epithelium of men with and without prostate cancer: evidence for a prostate cancer field effect. Clin Cancer Res (2010) 1.09

The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation: data from Southwest Oncology Group 8794. J Urol (2008) 1.02

Evaluating radical prostatectomy specimens: therapeutic and prognostic importance. Virchows Arch (1997) 0.91

Re-evaluating the concept of "dominant/index tumor nodule" in multifocal prostate cancer. Virchows Arch (2014) 0.84

Pathologic basis of focal therapy for early-stage prostate cancer. Nat Rev Urol (2009) 0.83

Value of magnetic resonance imaging in prostate cancer diagnosis. World J Urol (2007) 0.81

Utility of a herpes oncolytic virus for the detection of neural invasion by cancer. Neoplasia (2008) 0.81

Detection of prostate cancer with three-dimensional transrectal ultrasound: correlation with biopsy results. Br J Radiol (2011) 0.81

A new 5-grading score in the diagnosis of prostate cancer with real-time elastography. Int J Clin Exp Pathol (2014) 0.80

Seminal vesicle invasion by prostate cancer: prognostic significance and therapeutic implications. Rev Urol (2000) 0.79

The Gordon Wilson Lecture. Natural history and treatment of early stage prostate cancer. Trans Am Clin Climatol Assoc (2000) 0.79

Radical prostatectomy as radical cure of prostate cancer in a high-risk group: A single-institution experience. Mol Clin Oncol (2012) 0.77

The Utility of Diffusion Weighted Imaging (DWI) Using Apparent Diffusion Coefficient (ADC) Values in Discriminating Between Prostate Cancer and Normal Tissue. Pol J Radiol (2014) 0.76

Urethrogram-Directed Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer in Patients with Contraindications to Magnetic Resonance Imaging. Front Oncol (2015) 0.76

Carcinoma of the prostate. Can Fam Physician (1985) 0.75

Relationship Between Perineural Invasion in Prostate Needle Biopsy Specimens and Pathologic Staging After Radical Prostatectomy. Nephrourol Mon (2016) 0.75

Incidence of lymph node involvement in localized carcinoma of the prostate. J Natl Med Assoc (1984) 0.75

Target volume definition for post prostatectomy radiotherapy: Do the consensus guidelines correctly define the inferior border of the CTV? Rep Pract Oncol Radiother (2016) 0.75

Sexual function and the use of medical devices or drugs to optimize potency after prostate brachytherapy. Int J Radiat Oncol Biol Phys (2012) 0.75

Articles by these authors

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst (1989) 19.87

Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol (1985) 11.38

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol (1998) 7.61

The ecological fallacy. Am J Epidemiol (1988) 6.38

Randomized clinical trials. Perspectives on some recent ideas. N Engl J Med (1976) 5.86

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med (1980) 4.90

Proceedings: The Veterans Administration Cooperative Urological Research Group's studies of cancer of the prostate. Cancer (1973) 2.91

A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. Eur J Cancer (1979) 2.67

Renal medullary carcinoma. The seventh sickle cell nephropathy. Am J Surg Pathol (1995) 2.18

PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer. Proc Natl Acad Sci U S A (2000) 2.17

Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. JAMA (1995) 2.14

Proceedings: Testicular tumors. Epidemiologic, etiologic, and pathologic features. Cancer (1973) 1.88

Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age-referenced PSA, PSA density, and PSA change. Data from the American Cancer Society National Prostate Cancer Detection Project. Cancer (1994) 1.87

Intramitochondrial filamentous bodies in the thick limb of henle of the rat kidney. J Cell Biol (1967) 1.83

Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostate. Cancer (1970) 1.82

Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep (1983) 1.81

Angiomyofibroblastomalike tumor of the male genital tract: analysis of 11 cases with comparison to female angiomyofibroblastoma and spindle cell lipoma. Am J Surg Pathol (1998) 1.81

Why data bases should not replace randomized clinical trials. Biometrics (1980) 1.81

Precise localization of the autonomic nerves from the pelvic plexus to the corpora cavernosa: a detailed anatomical study of the adult male pelvis. J Urol (1985) 1.58

Aspects of statistical design for the Community Intervention Trial for Smoking Cessation (COMMIT). Control Clin Trials (1992) 1.58

Estrogen treatment for cancer of the prostate. Early results with 3 doses of diethylstilbestrol and placebo. Cancer (1970) 1.58

Orchiectomy for advanced prostatic carcinoma. A reevaluation. Urology (1973) 1.53

The dietary fat--breast cancer hypothesis is alive. JAMA (1989) 1.48

Metanephric adenoma. Clinicopathological study of fifty patients. Am J Surg Pathol (1995) 1.44

p53 and bcl-2 immunohistochemistry in pretreatment prostate needle biopsies to predict recurrence of prostate cancer after radical prostatectomy. J Urol (1999) 1.44

Armed Forces Institute of Pathology in jeopardy--who should care? Hum Pathol (2003) 1.38

Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China. Cancer Res (2000) 1.38

Decreased helper T lymphocytes in homosexual men. I. Sexual contact in high-incidence areas for the acquired immunodeficiency syndrome. Am J Epidemiol (1985) 1.37

Liesegang rings in tissue. How to distinguish Liesegang rings from the giant kidney worm, Dioctophyma renale. Am J Surg Pathol (1987) 1.33

Using observational data from registries to compare treatments: the fallacy of omnimetrics. Stat Med (1985) 1.32

Assessing the gain in efficiency due to matching in a community intervention study. Stat Med (1990) 1.30

Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy. J Urol (1996) 1.29

Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patients. J Urol (1999) 1.27

Body size and prostate cancer: a population-based case-control study in China. Cancer Epidemiol Biomarkers Prev (2000) 1.26

The results of a five-year early prostate cancer detection intervention. Investigators of the American Cancer Society National Prostate Cancer Detection Project. Cancer (1996) 1.25

Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: a report from the Testicular Cancer Intergroup Study. J Clin Oncol (1992) 1.21

Staging of early prostate cancer: a proposed tumor volume-based prognostic index. Urology (1993) 1.20

How many controls? J Chronic Dis (1976) 1.19

Overadjustment in case-control studies. Am J Epidemiol (1980) 1.16

Tests for homogeneity of effect in an epidemiologic investigation. Am J Epidemiol (1977) 1.16

Selecting optimal treatment in clinical trials using covariate information. J Chronic Dis (1977) 1.16

Factorial designs for randomized clinical trials. Cancer Treat Rep (1985) 1.14

Special report on Laetrile: the NCI Laetrile Review. Results of the National Cancer Institute's retrospective Laetrile analysis. N Engl J Med (1978) 1.11

The molecular characteristics of bladder cancer in young patients. J Urol (1998) 1.10

Proliferating cell nuclear antigen expression to predict occult disease in clinical stage I nonseminomatous testicular germ cell tumors. J Urol (1994) 1.10

Assessing apparent treatment--covariate interactions in randomized clinical trials. Stat Med (1985) 1.07

Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis. Cancer (1998) 1.07

Renal proliferative arteriopathies and associated glomerular changes: a light and electron microscopic study. Hum Pathol (1976) 1.07

Large acinar atypical hyperplasia and carcinoma of the prostate. Cancer (1988) 1.07

The choice of treatment for cancer patients based on covariate information. Bull Cancer (1980) 1.07

Insulin-like growth factors and prostate cancer: a population-based case-control study in China. Cancer Epidemiol Biomarkers Prev (2001) 1.06

Geographic distribution of motor neuron disease and correlation with possible etiologic factors. Neurology (1983) 1.06

Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer. J Urol (1996) 1.05

Prostate cancer, benign prostatic hyperplasia and physical activity in Shanghai, China. Int J Epidemiol (2001) 1.05

Carcinoid tumors of the testis. J Urol (1977) 1.04

Characteristics of prostate cancer detected in the American Cancer Society-National Prostate Cancer Detection Project. J Urol (1994) 1.02

Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer. Surgery (1996) 1.02

Estrogen predisposes to cholecystectomy but not to stones. Gastroenterology (1982) 1.01

Interpretation of biopsies of "normal" urothelium in patients with superficial bladder cancer. MRC Superficial Bladder Cancer Sub Group. Br J Urol (1991) 0.99

Pathology of germ cell tumors of testes. Prog Clin Biol Res (1985) 0.99

Prediction of prognosis in untreated stage A2 prostatic carcinoma. Cancer (1992) 0.98

Insulin-like growth factors and risk of benign prostatic hyperplasia. Prostate (2002) 0.98

Pathology of germ cell tumors of testis: a progress report. Cancer (1980) 0.98

The effect of stratified randomization on size and power of statistical tests in clinical trials. J Chronic Dis (1978) 0.97

Primary epithelial tumors of the bladder in the first two decades of life. J Urol (1969) 0.97

Histopathology of localized prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993. Scand J Urol Nephrol Suppl (1994) 0.97

Testing hypotheses in case-control studies--equivalence of Mantel-Haenszel statistics and logit score tests. Biometrics (1979) 0.97

Complete embedding and close step-sectioning of radical prostatectomy specimens both increase detection of extra-prostatic extension, and correlate with increased disease-free survival by stage of prostate cancer patients. Prostate Cancer Prostatic Dis (2002) 0.96

Updated concepts and treatment of carcinoma in situ. Urol Oncol (2011) 0.96

Relationship between estrogen receptor values and clinical data in predicting the response to endocrine therapy for patients with advanced breast cancer. Eur J Cancer (1979) 0.96

A clinicopathologic, histologic, and immunohistochemical study of mixed germ cell-stromal tumors of the testis in 16 dogs. Vet Pathol (1993) 0.96

Symptomatic plasmacytoma of the testis. Cancer (1970) 0.95

Clinical staging for cutaneous T-cell lymphoma. Ann Intern Med (1984) 0.95

Allelic loss on chromosome 6Q in primary prostate cancer. Int J Cancer (1999) 0.94

Inflammatory infiltrate (prostatitis) in whole mounted radical prostatectomy specimens from black and white patients is not an etiology for racial difference in prostate specific antigen. J Urol (2000) 0.94

A comparison of reflected versus test-based confidence intervals for the median survival time, based on censored data. Biometrics (1984) 0.94

The "WHO/ISUP Consensus Classification of Urothelial (Transitional Cell) Neoplasms": continued discussion. Hum Pathol (1999) 0.94

Treatment of prostatic cancer: studies by the Veterans Administration cooperative urological research group. Bull N Y Acad Med (1972) 0.94

Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China. Cancer Res (2001) 0.94

Grading of prostatic carcinoma. Cancer Chemother Rep (1975) 0.93

Survival after surgery for germinal malignancies of the testis. II. Effects of surgery and radiation therapy. Cancer (1972) 0.92

A proposal for registering clinical trials. Control Clin Trials (1988) 0.92

Survival of patients with incidentally found microscopic cancer of the prostate: results of a clinical trial of conservative treatment. J Urol (1972) 0.91

The distribution of 65zinc in the prostate and other organs in control, castrated, and hypophysectomized rats. Invest Urol (1969) 0.90

Observations on the early detection of prostate cancer from the American Cancer Society National Prostate Cancer Detection Project. Cancer (1997) 0.90

Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study. Cancer Epidemiol Biomarkers Prev (2001) 0.90

Patterns of glomerular reaction to injury. A teaching syllabus. Hum Pathol (1971) 0.89

Smooth muscle hyperplasia of the testicular adnexa clinically mimicking neoplasia: clinicopathologic study of sixteen cases. Am J Surg Pathol (1999) 0.89

Clinical predictivity of transplantable tumor systems in the selection of new drugs for solid tumors: rationale for a three-stage strategy. Cancer Treat Rep (1983) 0.88

Decreased helper T lymphocytes in homosexual men. II. Sexual practices. Am J Epidemiol (1985) 0.88

Testicular sparing surgery for prepubertal teratoma of the testis: a clinical and pathological study. J Urol (1990) 0.88

Reconsideration of orchiectomy in the treatment of advanced prostatic carcinoma. South Med J (1977) 0.88

Some interrelationships among the regression coefficient estimates arising in a class of models appropriate to response-time data. Biometrics (1975) 0.88

Status report of 376 mycosis fungoides patients at 4 years: Mycosis Fungoides Cooperative Group. Cancer Treat Rep (1979) 0.88

Placental alkaline phosphatase immunohistochemistry of intratubular malignant germ cells and associated testicular germ cell tumors. Hum Pathol (1988) 0.86

Carcinoma of prostate. Correlation between radiologic quantitation of metastases and patient survival. Urology (1975) 0.86

Cluster of testicular cancer in police officers exposed to hand-held radar. Am J Ind Med (1993) 0.86

Cancer of the prostate in men less than 50 years old: an analysis of 51 cases. J Urol (1969) 0.85

The role of retroperitoneal lymphadenectomy in mature teratoma of the testis. J Urol (1997) 0.85